Health Technology Regulation and Assessment

We address real world health technology issues to inform policy-making

Panos Kanavos, Programme Director, MTRG

HTA plays a crucial role in informing decision-making on the reimbursement of medical technologies globally. It is a multidisciplinary activity which studies the clinical and the cost effectiveness of new pharmaceuticals or any other medical interventions, as well as how health policy might be impacted by the new technology and what the social and ethical implications might be for patients and the wider society.


Our current Health Technology Regulation & Assessment research projects:

Impact-HTA: Improved methods and actionable tools for enhancing HTA

ESMO – Multi-criteria value framework for cancer products


Visit the Medical Technology Research Group website for more information on our LSE Consulting projects


Visit our past projects archive to find out about our past HTA research impacts